MSLN and ovarian cancer: In addition, the high expression of MSLN was significantly correlated with the decreased overall survival at different grades of ovarian cancer (Grade 1, p=0.0099; Grade 2, p=0.038; Grade 3, p=0.0037) (Figures 3, H−J).